Laurus Labs Ltd. (Laurus BSE: 540222, NSE: Lauruslabs, ISIN: INE947Q01010) has announced that the maiden USFDA audit for its Unit 4 was successfully completed without any observations and no form 483 issued. The inspection was carried out from 8th July 2019 - 12 July 2019.
Shares of Laurus Labs Ltd was last trading in BSE at Rs.354.05 as compared to the previous close of Rs. 345.95. The total number of shares traded during the day was 3951 in over 207 trades.
The stock hit an intraday high of Rs. 363.5 and intraday low of 340.45. The net turnover during the day was Rs. 1404042.